Konferenzen zum Thema Pharmakologie und Arzneimittelentwicklung in Deutschland

Wählen Sie ein Land aus
1
EMBL Conference: Expanding the Druggable Proteome with Chemical Biology
05. Feb 2020 - 07. Feb 2020 • Heidelberg, Deutschland
Zusammenfassung:
Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology .
Kontakt:
EMBL Events;     Tel.: [+49 6221 387 8797];     Email: events@embl.de
Themen:
Drug discovery, chemical biology, genomics, DNA-sensing pathways, proteolysis targeting chimeras (PROTACs), targeted protein degradation, druggable proteome, druggable genome, phenotypic screens, chemical probes, chemogenomics, bioinformatics
Eintrags-ID:
1242720
2
ITOC7 — 7th Immunotherapy of Cancer Conference
02. Apr 2020 - 04. Apr 2020 • München, Deutschland
Veranstalter:
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic
Zusammenfassung:
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Kontakt:
WMA GmbH Congress Office;     Tel.: [+431405138318];     Email: itoc@medacad.org
Themen:
Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy
Eintrags-ID:
1300607
Verwandte Fachgebiete:
3
ECI — Pharmaceutical Engineering: At the Frontier of Drug Substance and Drug Product
03. Mai 2020 - 07. Mai 2020 • Irsee, Deutschland
Veranstalter:
Engineering Conferences International (ECI)
Zusammenfassung:
It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.
Kontakt:
Tel.: [2125146760];     Email: noel@engconfintl.org
Themen:
Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)
Eintrags-ID:
1217731
4
DDSEU 2020 — 21st Annual Drug Discovery and 8th Annual Drug Design & Medicinal Chemistry Congress
26. Mai 2020 - 27. Mai 2020 • Berlin, Deutschland
Veranstalter:
Oxford Global
Zusammenfassung:
The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods.
Kontakt:
Tel.: [+441865248455];     Email: g.alonso@oxfordglobal.co.uk
Themen:
Drug Discovery, Drug Design, Medicinal Chemistry
Eintrags-ID:
1301553
5
NEURO2020 — 2nd Annual Neuroscience Drug Discovery Congress
26. Mai 2020 - 27. Mai 2020 • Berlin, Deutschland
Veranstalter:
Oxford Global
Zusammenfassung:
Oxford Global is proud to present our 2nd Annual Neuroscience Drug Discovery Congress, taking place 26 – 27 May 2020 in Berlin, Germany, which will bring together key leaders and influencers from global pharmaceutical organisations and leading academic research institutions. Discover the latest developments and critical approaches in neuroscience discovery, alongside cutting-edge enabling tools and technologies for developing neurological treatments. The congress encompasses the emerging trends and technological breakthroughs in drug discovery for neurodegenerative diseases, together with presentations on advancements in stem cell technologies to fuel drug discovery and iPS cells in disease modelling. On Day 2, we aim to emphasise the importance of targeted therapeutics and the crucial roles of biomarker development and gene therapy in drug discovery and translational neuroscience.

Key speakers include:

• Emilio Merlo Pich, Executive Director Neurology & Quantitative Medicine Neuroscience Therapeutic Area, Takeda

• Andreas Hartmann, Executive Director PreClinical Safety, Therapeutic Area Head, Novartis

• Ross Jeggo, Head of Research, Neuropsychiatry Centre for Therapeutic Innovation, Servier

View the Agenda: https://bit.ly/2rYH2kT

With over 20 unmissable presentations, the two-day congress offers an intuitive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

This events form part of the R&D Series EU and are co-located with our 21st Annual Drug Discovery Summit and 8th Annual Drug Design & Medicinal Chemistry Congress

For more information contact g.alonso@oxfordglobal.co.uk or visit the website: https://bit.ly/2PfND2z

Go Social: Join our Drug Discovery & Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and & join the conversation at #RNDSeries20

LIVE WEBINAR:

Predictive Model Approaches For Pharmacokinetics And Pharmacodynamics In CNS Discovery

Hosted by Elizabeth de Lange, Professor in Predictive Pharmacology, LACDR, Leiden University

Register (free): https://bit.ly/2RQHjBg

Kontakt:
Tel.: [+441865248455];     Email: g.alonso@oxfordglobal.co.uk
Themen:
Neuroscience, Drug Discovery, Drug Development, Drug Design, Medicinal Chemistry
Eintrags-ID:
1307066
Verwandte Fachgebiete:


Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Stand vom 13. Dezember 2019